Pain Management Devices Market by Type (Neurostimulation, Infusion Pump, Ablation), Application (Neuropathic, Musculoskeletal, Cancer pain), Mode of Purchase (Prescription, OTC), By End user (Hospital, Physiotherapy, Home care) - Global Forecast to 2029

1.1 Study Objectives
1.2 Market Definition
1.2.1 Inclusions and Exclusions
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Years Considered
1.3.3 Currency Considered
1.4 Stakeholders
1.5 Summary of Changes

2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data from Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data from Primary Sources
2.1.2.2 Insights from Industry Experts
2.1.2.3 Breakdown of Primary Interviews
2.1.2.4 Supply-Side and Demand-Side Participants
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Data Triangulation
2.4 Research Assumptions
2.5 Research Limitations
2.6 Risk Assessment

4.1 Attractive Opportunities for Players in Pain Management Devices Market
4.2 Asia-Pacific Pain Management Devices Market, by Application and Country
4.3 Pain Management Devices Market, by Country

5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Surge in Demand for At-Home Pain Management Devices
5.2.1.2 Increase in Surgical Procedures
5.2.1.3 Prevalence of Chronic Pain Conditions
5.2.1.4 Favorable Reimbursement Policies for Spinal Cord Stimulation Devices
5.2.1.5 Growing Launches and Regulatory Approvals for Advanced Pain Management Devices
5.2.2 Restraints
5.2.2.1 Rise in Product Recalls
5.2.2.2 High Procedural and Purchase Cost of Pain Management Devices
5.2.3 Opportunities
5.2.3.1 Untapped Growth Potential in Emerging Economies
5.2.3.2 Expansion of Pain Management Clinics
5.2.4 Challenges
5.2.4.1 Use of Pain Medication as First Line of Treatment
5.2.4.2 Stringent Regulatory Norms for Fda Approval
5.3 Technology Analysis
5.3.1 Key Technologies
5.3.1.1 Wearable Devices
5.3.1.2 Implantable Pumps
5.3.2 Complementary Technologies
5.3.2.1 Virtual Reality
5.3.2.2 Digital Therapeutics
5.3.3 Adjacent Technologies
5.3.3.1 Robotics
5.4 Industry Trends
5.4.1 Electrotherapy Devices
5.4.2 Rechargeable Spinal Cord Stimulators
5.5 Supply Chain Analysis
5.6 Trade Analysis
5.7 Porter's Five Forces Analysis
5.7.1 Threat from New Entrants
5.7.2 Threat from Substitutes
5.7.3 Bargaining Power of Suppliers
5.7.4 Bargaining Power of Buyers
5.7.5 Intensity of Competitive Rivalry
5.8 Regulatory Landscape
5.8.1 North America
5.8.1.1 US
5.8.1.2 Canada
5.8.2 Europe
5.8.3 Asia-Pacific
5.8.3.1 Japan
5.8.3.2 China
5.8.3.3 India
5.8.4 Latin America
5.8.4.1 Brazil
5.8.4.2 Mexico
5.8.5 Regulatory Bodies, Government Agencies, and Other Organizations
5.9 Patent Analysis
5.10 Pricing Analysis
5.11 Key Conferences and Events, 2024-2025
5.12 Key Stakeholders and Buying Criteria
5.12.1 Key Stakeholders in Buying Process
5.12.2 Buying Criteria
5.13 Ecosystem Analysis
5.14 Case Study Analysis
5.15 Reimbursement Analysis
5.16 Unmet Needs in Pain Management Devices Market
5.17 Value Chain Analysis
5.18 End-user Expectations in Pain Management Devices Market
5.19 Impact of AI/Gen AI in Pain Management Devices Market
5.20 Trends and Disruptions Impacting Customers’ Businesses
5.21 Investment and Funding Scenario

6.1 Introduction
6.2 Neurostimulation Devices
6.2.1 Transcutaneous Electrical Nerve Stimulators
6.2.1.1 Surge in Demand for Non-Invasive Therapy to Drive Market
6.2.2 Spinal Cord Stimulators
6.2.2.1 Extensive Use of Scs for Pain Treatment to Drive Market
6.2.3 Others
6.3 Infusion Pumps
6.3.1 Intrathecal Infusion Pumps
6.3.1.1 Increasing Incidences of Chronic Pain to Drive Market
6.3.2 External Infusion Pumps
6.3.2.1 Availability of Reimbursement to Drive Market
6.4 Ablation Devices
6.4.1 Radiofrequency Ablation Devices
6.4.1.1 Low Cost of Rf Ablation Procedures to Drive Market
6.4.2 Cryoablation Ablation Devices
6.4.2.1 Successful Clinical Trials to Drive Market
6.4.3 Ultrasound Ablation Devices
6.4.3.1 Efficacy in Targeted Pain Management to Drive Market
6.4.4 Others

7.1 Introduction
7.2 Neuropathic Pain
7.2.1 High Efficacy of Pain Management Devices in Neuropathic Pain Treatment to Drive Market
7.3 Musculoskeletal Pain
7.3.1 Surge in Aging Population to Drive Market
7.4 Cancer Pain
7.4.1 Prevalence of Cancer to Drive Market
7.5 Facial Pain & Migraine
7.5.1 Introduction of Novel Pain Management Devices to Drive Market
7.6 Other Applications

8.1 Introduction
8.2 Prescription-based
8.2.1 Increasing Incidences of Medical Disorders to Drive Market
8.3 Over-The-Counter
8.3.1 Accessibility of OTC Pain Management Devices to Drive Market

9.1 Introduction
9.2 Hospitals & Clinics
9.3 Physiotherapy Centers
9.3.1 Rise of Sports Injuries and Musculoskeletal Disorders To Drive Market
9.4 Home Care Settings
9.4.1 High Cost of Hospitalization to Drive Market
9.5 Other End-users

10.1 Introduction
10.2 North America
10.2.1 Macroeconomic Outlook
10.2.2 US
10.2.2.1 Favorable Reimbursement Policies to Drive Market
10.2.3 Canada
10.2.3.1 Increasing Incidences of Chronic Pain to Drive Market
10.3 Europe
10.3.1 Macroeconomic Outlook
10.3.2 Germany
10.3.2.1 Robust Healthcare Infrastructure to Drive Market
10.3.3 France
10.3.3.1 Government Initiatives for Lowering Healthcare Costs to Drive Market
10.3.4 UK
10.3.4.1 Shift Toward Home Care Settings to Drive Market
10.3.5 Italy
10.3.5.1 Growing Healthcare Investments to Drive Market
10.3.6 Spain
10.3.6.1 Surge in New Cancer Cases to Drive Market
10.3.7 Rest of Europe
10.4 Asia-Pacific
10.4.1 Macroeconomic Outlook
10.4.2 Japan
10.4.2.1 Large Geriatric Population to Drive Market
10.4.3 China
10.4.3.1 Growing Investments in Healthcare Infrastructure Development to Drive Market
10.4.4 India
10.4.4.1 High Prevalence of Lifestyle Diseases to Drive Market
10.4.5 Australia
10.4.5.1 Initiatives Promoting Development of Novel Pain Management Devices to Drive Market
10.4.6 South Korea
10.4.6.1 Growing Demand for Effective Treatment Options to Drive Market
10.4.7 Rest of Asia-Pacific
10.5 Latin America
10.5.1 Macroeconomic Outlook
10.5.2 Brazil
10.5.2.1 Private and Government Sector Awareness Programs to Drive Market
10.5.3 Mexico
10.5.3.1 Domestic Health Coverage Schemes to Drive Market
10.5.4 Rest of Latin America
10.6 Middle East & Africa
10.6.1 Macroeconomic Outlook
10.6.2 GCC Countries
10.6.2.1 High Healthcare Spending Capacity to Drive Market
10.6.3 Rest of Middle East & Africa

11.1 Introduction
11.2 Key Player Strategies/Right to Win, 2021-2024
11.3 Revenue Analysis, 2021-2023
11.4 Market Share Analysis, 2023
11.5 Company Evaluation Matrix: Key Players, 2023
11.5.1 Stars
11.5.2 Emerging Leaders
11.5.3 Pervasive Players
11.5.4 Participants
11.5.5 Company Footprint
11.5.5.1 Company Footprint
11.5.5.2 Type Footprint
11.5.5.3 Region Footprint
11.6 Company Evaluation Matrix: Start-Ups/SMEs, 2023
11.6.1 Progressive Companies
11.6.2 Responsive Companies
11.6.3 Dynamic Companies
11.6.4 Starting Blocks
11.6.5 Competitive Benchmarking
11.7 Brand/Product Comparison
11.8 R&D Assessment
11.9 Company Valuation and Financial Metrics
11.10 Competitive Scenario
11.10.1 Product Approvals/Launches
11.10.2 Deals
11.10.3 Expansions
11.10.4 Others

12.1 Key Players
12.1.1 Medtronic
12.1.1.1 Business Overview
12.1.1.2 Products Offered
12.1.1.3 Recent Developments
12.1.1.3.1 Product Approvals/Launches
12.1.1.4 Analyst's View
12.1.1.4.1 Key Strengths
12.1.1.4.2 Strategic Choices
12.1.1.4.3 Weaknesses and Competitive Threats
12.1.2 Boston Scientific Corporation
12.1.2.1 Business Overview
12.1.2.2 Products Offered
12.1.2.3 Recent Developments
12.1.2.3.1 Deals
12.1.2.4 Analyst's View
12.1.2.4.1 Key Strengths
12.1.2.4.2 Strategic Choices
12.1.2.4.3 Weaknesses and Competitive Threats
12.1.3 Abbott Laboratories
12.1.3.1 Business Overview
12.1.3.2 Product Offered
12.1.3.3 Recent Developments
12.1.3.3.1 Product Approvals/Launches
12.1.3.4 Analyst's View
12.1.3.4.1 Key Strengths
12.1.3.4.2 Strategic Choices
12.1.3.4.3 Weaknesses and Competitive Threats
12.1.4 Nevro Corp.
12.1.4.1 Business Overview
12.1.4.2 Products Offered
12.1.4.3 Recent Developments
12.1.4.3.1 Product Approvals/Launches
12.1.4.3.2 Deals
12.1.4.4 Analyst's View
12.1.4.4.1 Key Strengths
12.1.4.4.2 Strategic Choices
12.1.4.4.3 Weaknesses and Competitive Threats
12.1.5 Becton, Dickinson and Company
12.1.5.1 Business Overview
12.1.5.2 Products Offered
12.1.5.3 Recent Developments
12.1.5.3.1 Others
12.1.5.4 Analyst's View
12.1.5.4.1 Right to Win
12.1.5.4.2 Strategic Choices
12.1.5.4.3 Weaknesses and Competitive Threats
12.1.6 Stryker
12.1.6.1 Business Overview
12.1.6.2 Products Offered
12.1.6.3 Recent Developments
12.1.6.3.1 Expansions
12.1.7 B. Braun SE
12.1.7.1 Business Overview
12.1.7.2 Products Offered
12.1.7.3 Recent Developments
12.1.7.3.1 Deals
12.1.7.3.2 Others
12.1.8 Baxter
12.1.8.1 Business Overview
12.1.8.2 Products Offered
12.1.9 Omron Corporation
12.1.9.1 Business Overview
12.1.9.2 Products Offered
12.1.10 Avanos Medical, Inc.
12.1.10.1 Business Overview
12.1.10.2 Products Offered
12.1.10.2.1 Deals
12.1.11 Teleflex Incorporated
12.1.11.1 Business Overview
12.1.11.2 Products Offered
12.1.12 Icu Medical, Inc.
12.1.12.1 Business Overview
12.1.12.2 Products Offered
12.1.12.3 Recent Developments
12.1.12.3.1 Deals
12.1.13 Nipro
12.1.13.1 Business Overview
12.1.13.2 Products Offered
12.1.13.3 Recent Developments
12.1.13.3.1 Expansions
12.1.14 Moog Inc.
12.1.14.1 Business Overview
12.1.14.2 Products Offered
12.1.15 Atricure, Inc.
12.1.15.1 Business Overview
12.1.15.2 Products Offered
12.1.15.3 Recent Developments
12.1.15.3.1 Product Approvals/Launches
12.1.16 Micrel Medical Devices SA
12.1.16.1 Business Overview
12.1.16.2 Products Offered
12.1.17 Zynex, Inc.
12.1.17.1 Business Overview
12.1.17.2 Products Offered
12.1.18 Enovis Corporation
12.1.18.1 Business Overview
12.1.18.2 Products Offered
12.2 Other Players
12.2.1 Epic Medical
12.2.2 Soterix Medical Inc.
12.2.3 Gimer Medical
12.2.4 Neuronano Ab
12.2.5 Icecure Medical
12.2.6 Biowave
12.2.7 Theranica Bio-Electronics Ltd.

13.1 Discussion Guide
13.2 Knowledgestore: The Subscription Portal
13.3 Customization Options

Table 1 Standard Exchange Rates
Table 2 Import Data for HS Code 901890, by Country, 2019-2023 (USD Thousand)
Table 3 Export Data for HS Code 901890, by Country, 2019-2023 (USD Thousand)
Table 4 Impact of Porter's Five Forces
Table 5 Indicative List of Regulatory Authorities Governing Pain Management Devices
Table 6 US Fda: Medical Device Classification
Table 7 US: Classification of Medical Devices
Table 8 Canada: Classification of Medical Devices
Table 9 Japan: Classification of Medical Devices
Table 10 China: Classification of Medical Devices
Table 11 Brazil: Classification of Medical Devices
Table 12 Mexico: Classification of Medical Devices
Table 13 North America: Regulatory Bodies, Government Agencies, and Other Organizations
Table 14 Europe: Regulatory Bodies, Government Agencies, and Other Organizations
Table 15 Asia-Pacific: Regulatory Bodies, Government Agencies, and Other Organizations
Table 16 Latin America: Regulatory Bodies, Government Agencies, and Other Organizations
Table 17 Middle East & Africa: Regulatory Bodies, Government Agencies, and Other Organizations
Table 18 Patent Analysis, 2023-2024
Table 19 Indicative Pricing of Pain Management Devices, by Region, 2023 (USD)
Table 20 Key Conferences and Events, 2024-2025
Table 21 Influence of Stakeholders on Buying Process, by Type (%)
Table 22 Key Buying Criteria, by Type
Table 23 Role of Companies in Ecosystem
Table 24 Celiac Plexus Cryo-Neurolysis for Palliative Pain Management in Pancreatic Cancer
Table 25 Get Ready Remote Patient Management Solution for Timely Chronic Pain Treatment Of
Table 26 Medicare Coding and National Payment Rates for Radiofrequency Ablation (Sacroiliac Joint) Procedures
Table 27 Medicare Coding and National Physician Payment Rates for Spinal Cord Stimulation Procedures
Table 28 Pain Management Devices Market, by Type, 2022-2029 (USD Million)
Table 29 Neurostimulation Devices Market, by Type, 2022-2029 (USD Million)
Table 30 Neurostimulation Devices Market, by Country, 2022-2029 (USD Million)
Table 31 Transcutaneous Electrical Nerve Stimulators Market, by Country, 2022-2029 (USD Million)
Table 32 Spinal Cord Stimulators Market, by Country, 2022-2029 (USD Million)
Table 33 Other Neurostimulation Devices Market, by Country, 2022-2029 (USD Million)
Table 34 Infusion Pumps Market, by Type, 2022-2029 (USD Million)
Table 35 Infusion Pumps Market, by Country, 2022-2029 (USD Million)
Table 36 Intrathecal Infusion Pumps Market, by Country, 2022-2029 (USD Million)
Table 37 External Infusion Pumps Market, by Country, 2022-2029 (USD Million)
Table 38 Ablation Devices Market, by Type, 2022-2029 (USD Million)
Table 39 Ablation Devices Market, by Country, 2022-2029 (USD Million)
Table 40 Rf Ablation Devices Market, by Country, 2022-2029 (USD Million)
Table 41 Cryoablation Devices Market, by Country, 2022-2029 (USD Million)
Table 42 Ultrasound Devices Market, by Country, 2022-2029 (USD Million)
Table 43 Other Ablation Devices Market, by Country, 2022-2029 (USD Million)
Table 44 Pain Management Devices Market, by Application, 2022-2029 (USD Million)
Table 45 Neuropathic Pain Management Devices Market, by Country, 2022-2029 (USD Million)
Table 46 Musculoskeletal Pain Management Devices Market, by Country, 2022-2029 (USD Million)
Table 47 Cancer Pain Management Devices Market, by Country, 2022-2029 (USD Million)
Table 48 Facial Pain & Migraine Management Devices Market, by Country, 2022-2029 (USD Million)
Table 49 Other Pain Management Devices Market, by Country, 2022-2029 (USD Million)
Table 50 Pain Management Devices Market, by Mode of Purchase, 2022-2029 (USD Million)
Table 51 Prescription-based Pain Management Devices Market, by Country, 2022-2029 (USD Million)
Table 52 Over-The-Counter Pain Management Devices Market, by Country, 2022-2029 (USD Million)
Table 53 Pain Management Devices Market, by End-user, 2022-2029 (USD Million)
Table 54 Pain Management Devices Market for Hospitals & Clinics, by Country, 2022-2029 (USD Million)
Table 55 Pain Management Devices Market for Physiotherapy Clinics, By Country, 2022-2029 (USD Million)
Table 56 Pain Management Devices Market for Home Care Settings, by Country, 2022-2029 (USD Million)
Table 57 Pain Management Devices Market for Others, by Country, 2022-2029 (USD Million)
Table 58 Pain Management Devices Market, by Region, 2022-2029 (USD Million)
Table 59 North America: Pain Management Devices Market, by Country, 2022-2029 (USD Million)
Table 60 North America: Pain Management Devices Market, by Type, 2022-2029 (USD Million)
Table 61 North America: Neurostimulation Devices Market, by Type, 2022-2029 (USD Million)
Table 62 North America: Infusion Pumps Market, by Type, 2022-2029 (USD Million)
Table 63 North America: Ablation Devices Market, by Type, 2022-2029 (USD Million)
Table 64 North America: Pain Management Devices Market, by Application, 2022-2029 (USD Million)
Table 65 North America: Pain Management Devices Market, by Mode of Purchase, 2022-2029 (USD Million)
Table 66 North America: Pain Management Devices Market, by End-user, 2022-2029 (USD Million)
Table 67 North America: Key Macro Indicators
Table 68 US: Pain Management Devices Market, by Type, 2022-2029 (USD Million)
Table 69 US: Neurostimulation Devices Market, by Type, 2022-2029 (USD Million)
Table 70 US: Infusion Pumps Market, by Type, 2022-2029 (USD Million)
Table 71 US: Ablation Devices Market, by Type, 2022-2029 (USD Million)
Table 72 US: Pain Management Devices Market, by Application, 2022-2029 (USD Million)
Table 73 US: Pain Management Devices Market, by Mode of Purchase, 2022-2029 (USD Million)
Table 74 US: Pain Management Devices Market, by End-user, 2022-2029 (USD Million)
Table 75 Canada: Pain Management Devices Market, by Type, 2022-2029 (USD Million)
Table 76 Canada: Neurostimulation Devices Market, by Type, 2022-2029 (USD Million)
Table 77 Canada: Infusion Pumps Market, by Type, 2022-2029 (USD Million)
Table 78 Canada: Ablation Devices Market, by Type, 2022-2029 (USD Million)
Table 79 Canada: Pain Management Devices Market, by Application, 2022-2029 (USD Million)
Table 80 Canada: Pain Management Devices Market, by Mode of Purchase, 2022-2029 (USD Million)
Table 81 Canada: Pain Management Devices Market, by End-user, 2022-2029 (USD Million)
Table 82 Europe: Pain Management Devices Market, by Country, 2022-2029 (USD Million)
Table 83 Europe: Pain Management Devices Market, by Type, 2022-2029 (USD Million)
Table 84 Europe: Neurostimulation Devices Market, by Type, 2022-2029 (USD Million)
Table 85 Europe: Infusion Pumps Market, by Type, 2022-2029 (USD Million)
Table 86 Europe: Ablation Devices Market, by Type, 2022-2029 (USD Million)
Table 87 Europe: Pain Management Devices Market, by Application, 2022-2029 (USD Million)
Table 88 Europe: Pain Management Devices Market, by Mode of Purchase, 2022-2029 (USD Million)
Table 89 Europe: Pain Management Devices Market, by End-user, 2022-2029 (USD Million)
Table 90 Europe: Key Macro Indicators
Table 91 Germany: Pain Management Devices Market, by Type, 2022-2029 (USD Million)
Table 92 Germany: Neurostimulation Devices Market, by Type, 2022-2029 (USD Million)
Table 93 Germany: Infusion Pumps Market, by Type, 2022-2029 (USD Million)
Table 94 Germany: Ablation Devices Market, by Type, 2022-2029 (USD Million)
Table 95 Germany: Pain Management Devices Market, by Application, 2022-2029 (USD Million)
Table 96 Germany: Pain Management Devices Market, by Mode of Purchase, 2022-2029 (USD Million)
Table 97 Germany: Pain Management Devices Market, by End-user, 2022-2029 (USD Million)
Table 98 France: Pain Management Devices Market, by Type, 2022-2029 (USD Million)
Table 99 France: Neurostimulation Devices Market, by Type, 2022-2029 (USD Million)
Table 100 France: Infusion Pumps Market, by Type, 2022-2029 (USD Million)
Table 101 France: Ablation Devices Market, by Type, 2022-2029 (USD Million)
Table 102 France: Pain Management Devices Market, by Application, 2022-2029 (USD Million)
Table 103 France: Pain Management Devices Market, by Mode of Purchase, 2022-2029 (USD Million)
Table 104 France: Pain Management Devices Market, by End-user, 2022-2029 (USD Million)
Table 105 UK: Pain Management Devices Market, by Type, 2022-2029 (USD Million)
Table 106 UK: Neurostimulation Devices Market, by Type, 2022-2029 (USD Million)
Table 107 UK: Infusion Pumps Market, by Type, 2022-2029 (USD Million)
Table 108 UK: Ablation Devices Market, by Type, 2022-2029 (USD Million)
Table 109 UK: Pain Management Devices Market, by Application, 2022-2029 (USD Million)
Table 110 UK: Pain Management Devices Market, by Mode of Purchase, 2022-2029 (USD Million)
Table 111 UK: Pain Management Devices Market, by End-user, 2022-2029 (USD Million)
Table 112 Italy: Pain Management Devices Market, by Type, 2022-2029 (USD Million)
Table 113 Italy: Neurostimulation Devices Market, by Type, 2022-2029 (USD Million)
Table 114 Italy: Infusion Pumps Market, by Type, 2022-2029 (USD Million)
Table 115 Italy: Ablation Devices Market, by Type, 2022-2029 (USD Million)
Table 116 Italy: Pain Management Devices Market, by Application, 2022-2029 (USD Million)
Table 117 Italy: Pain Management Devices Market, by Mode of Purchase, 2022-2029 (USD Million)
Table 118 Italy: Pain Management Devices Market, by End-user, 2022-2029 (USD Million)
Table 119 Spain: Pain Management Devices Market, by Type, 2022-2029 (USD Million)
Table 120 Spain: Neurostimulation Devices Market, by Type, 2022-2029 (USD Million)
Table 121 Spain: Infusion Pumps Market, by Type, 2022-2029 (USD Million)
Table 122 Spain: Ablation Devices Market, by Type, 2022-2029 (USD Million)
Table 123 Spain: Pain Management Devices Market, by Application, 2022-2029 (USD Million)
Table 124 Spain: Pain Management Devices Market, by Mode of Purchase, 2022-2029 (USD Million)
Table 125 Spain: Pain Management Devices Market, by End-user, 2022-2029 (USD Million)
Table 126 Rest of Europe: Pain Management Devices Market, by Type, 2022-2029 (USD Million)
Table 127 Rest of Europe: Neurostimulation Devices Market, by Type, 2022-2029 (USD Million)
Table 128 Rest of Europe: Infusion Pumps Market, by Type, 2022-2029 (USD Million)
Table 129 Rest of Europe: Ablation Devices Market, by Type, 2022-2029 (USD Million)
Table 130 Rest of Europe: Pain Management Devices Market, by Application, 2022-2029 (USD Million)
Table 131 Rest of Europe: Pain Management Devices Market, By Mode of Purchase, 2022-2029 (USD Million)
Table 132 Rest of Europe: Pain Management Devices Market, by End-user, 2022-2029 (USD Million)
Table 133 Asia-Pacific: Pain Management Devices Market, by Country, 2022-2029 (USD Million)
Table 134 Asia-Pacific: Pain Management Devices Market, by Type, 2022-2029 (USD Million)
Table 135 Asia-Pacific: Neurostimulation Devices Market, by Type, 2022-2029 (USD Million)
Table 136 Asia-Pacific: Infusion Pumps Market, by Type, 2022-2029 (USD Million)
Table 137 Asia-Pacific: Ablation Devices Market, by Type, 2022-2029 (USD Million)
Table 138 Asia-Pacific: Pain Management Devices Market, by Application, 2022-2029 (USD Million)
Table 139 Asia-Pacific: Pain Management Devices Market, by Mode of Purchase, 2022-2029 (USD Million)
Table 140 Asia-Pacific: Pain Management Devices Market, by End-user, 2022-2029 (USD Million)
Table 141 Asia-Pacific: Key Macro Indicators
Table 142 Japan: Pain Management Devices Market, by Type, 2022-2029 (USD Million)
Table 143 Japan: Neurostimulation Devices Market, by Type, 2022-2029 (USD Million)
Table 144 Japan: Infusion Pumps Market, by Type, 2022-2029 (USD Million)
Table 145 Japan: Ablation Devices Market, by Type, 2022-2029 (USD Million)
Table 146 Japan: Pain Management Devices Market, by Application, 2022-2029 (USD Million)
Table 147 Japan: Pain Management Devices Market, by Mode of Purchase, 2022-2029 (USD Million)
Table 148 Japan: Pain Management Devices Market, by End-user, 2022-2029 (USD Million)
Table 149 China: Pain Management Devices Market, by Type, 2022-2029 (USD Million)
Table 150 China: Neurostimulation Devices Market, by Type, 2022-2029 (USD Million)
Table 151 China: Infusion Pumps Market, by Type, 2022-2029 (USD Million)
Table 152 China: Ablation Devices Market, by Type, 2022-2029 (USD Million)
Table 153 China: Pain Management Devices Market, by Application, 2022-2029 (USD Million)
Table 154 China: Pain Management Devices Market, by Mode of Purchase, 2022-2029 (USD Million)
Table 155 China: Pain Management Devices Market, by End-user, 2022-2029 (USD Million)
Table 156 India: Pain Management Devices Market, by Type, 2022-2029 (USD Million)
Table 157 India: Neurostimulation Devices Market, by Type, 2022-2029 (USD Million)
Table 158 India: Infusion Pumps Market, by Type, 2022-2029 (USD Million)
Table 159 India: Ablation Devices Market, by Type, 2022-2029 (USD Million)
Table 160 India: Pain Management Devices Market, by Application, 2022-2029 (USD Million)
Table 161 India: Pain Management Devices Market, by Mode of Purchase, 2022-2029 (USD Million)
Table 162 India: Pain Management Devices Market, by End-user, 2022-2029 (USD Million)
Table 163 Australia: Pain Management Devices Market, by Type, 2022-2029 (USD Million)
Table 164 Australia: Neurostimulation Devices Market, by Type, 2022-2029 (USD Million)
Table 165 Australia: Infusion Pumps Market, by Type, 2022-2029 (USD Million)
Table 166 Australia: Ablation Devices Market, by Type, 2022-2029 (USD Million)
Table 167 Australia: Pain Management Devices Market, by Application, 2022-2029 (USD Million)
Table 168 Australia: Pain Management Devices Market, by Mode of Purchase, 2022-2029 (USD Million)
Table 169 Australia: Pain Management Devices Market, by End-user, 2022-2029 (USD Million)
Table 170 South Korea: Pain Management Devices Market, by Type, 2022-2029 (USD Million)
Table 171 South Korea: Neurostimulation Devices Market, by Type, 2022-2029 (USD Million)
Table 172 South Korea: Infusion Pumps Market, by Type, 2022-2029 (USD Million)
Table 173 South Korea: Ablation Devices Market, by Type, 2022-2029 (USD Million)
Table 174 South Korea: Pain Management Devices Market, by Application, 2022-2029 (USD Million)
Table 175 South Korea: Pain Management Devices Market, by Mode of Purchase, 2022-2029 (USD Million)
Table 176 South Korea: Pain Management Devices Market, by End-user, 2022-2029 (USD Million)
Table 177 Rest of Asia-Pacific: Pain Management Devices Market, by Type, 2022-2029 (USD Million)
Table 178 Rest of Asia-Pacific: Neurostimulation Devices Market, by Type, 2022-2029 (USD Million)
Table 179 Rest of Asia-Pacific: Infusion Pumps Market, by Type, 2022-2029 (USD Million)
Table 180 Rest of Asia-Pacific: Ablation Devices Market, by Type, 2022-2029 (USD Million)
Table 181 Rest of Asia-Pacific: Pain Management Devices Market, by Application, 2022-2029 (USD Million)
Table 182 Rest of Asia-Pacific: Pain Management Devices Market, By Mode of Purchase, 2022-2029 (USD Million)
Table 183 Rest of Asia-Pacific: Pain Management Devices Market, by End-user, 2022-2029 (USD Million)
Table 184 Latin America: Pain Management Devices Market, by Country, 2022-2029 (USD Million)
Table 185 Latin America: Pain Management Devices Market, by Type, 2022-2029 (USD Million)
Table 186 Latin America: Neurostimulation Devices Market, by Type, 2022-2029 (USD Million)
Table 187 Latin America: Infusion Pumps Market, by Type, 2022-2029 (USD Million)
Table 188 Latin America: Ablation Devices Market, by Type, 2022-2029 (USD Million)
Table 189 Latin America: Pain Management Devices Market, by Application, 2022-2029 (USD Million)
Table 190 Latin America: Pain Management Devices Market, by Mode of Purchase, 2022-2029 (USD Million)
Table 191 Latin America: Pain Management Devices Market, by End-user, 2022-2029 (USD Million)
Table 192 Latin America: Key Macro Indicators
Table 193 Brazil: Pain Management Devices Market, by Type, 2022-2029 (USD Million)
Table 194 Brazil: Neurostimulation Devices Market, by Type, 2022-2029 (USD Million)
Table 195 Brazil: Infusion Pumps Market, by Type, 2022-2029 (USD Million)
Table 196 Brazil: Ablation Devices Market, by Type, 2022-2029 (USD Million)
Table 197 Brazil: Pain Management Devices Market, by Application, 2022-2029 (USD Million)
Table 198 Brazil: Pain Management Devices Market, by Mode of Purchase, 2022-2029 (USD Million)
Table 199 Brazil: Pain Management Devices Market, by End-user, 2022-2029 (USD Million)
Table 200 Mexico: Pain Management Devices Market, by Type, 2022-2029 (USD Million)
Table 201 Mexico: Neurostimulation Devices Market, by Type, 2022-2029 (USD Million)
Table 202 Mexico: Infusion Pumps Market, by Type, 2022-2029 (USD Million)
Table 203 Mexico: Ablation Devices Market, by Type, 2022-2029 (USD Million)
Table 204 Mexico: Pain Management Devices Market, by Application, 2022-2029 (USD Million)
Table 205 Mexico: Pain Management Devices Market, by Mode of Purchase, 2022-2029 (USD Million)
Table 206 Mexico: Pain Management Devices Market, by End-user, 2022-2029 (USD Million)
Table 207 Rest of Latin America: Pain Management Devices Market, by Type, 2022-2029 (USD Million)
Table 208 Rest of Latin America: Neurostimulation Devices Market, by Type, 2022-2029 (USD Million)
Table 209 Rest of Latin America: Infusion Pumps Market, by Type, 2022-2029 (USD Million)
Table 210 Rest of Latin America: Ablation Devices Market, by Type, 2022-2029 (USD Million)
Table 211 Rest of Latin America: Pain Management Devices Market, by Application, 2022-2029 (USD Million)
Table 212 Rest of Latin America: Pain Management Devices Market, By Mode of Purchase, 2022-2029 (USD Million)
Table 213 Rest of Latin America: Pain Management Devices Market, by End-user, 2022-2029 (USD Million)
Table 214 Middle East & Africa: Pain Management Devices Market, by Country, 2022-2029 (USD Million)
Table 215 Middle East & Africa: Pain Management Devices Market, by Type, 2022-2029 (USD Million)
Table 216 Middle East & Africa: Neurostimulation Devices Market, by Type, 2022-2029 (USD Million)
Table 217 Middle East & Africa: Infusion Pumps Market, by Type, 2022-2029 (USD Million)
Table 218 Middle East & Africa: Ablation Devices Market, by Type, 2022-2029 (USD Million)
Table 219 Middle East & Africa: Pain Management Devices Market, by Application, 2022-2029 (USD Million)
Table 220 Middle East & Africa: Pain Management Devices Market, By Mode of Purchase, 2022-2029 (USD Million)
Table 221 Middle East & Africa: Pain Management Devices Market, by End-user, 2022-2029 (USD Million)
Table 222 Middle East & Africa: Key Macro Indicators
Table 223 GCC Countries: Pain Management Devices Market, by Type, 2022-2029 (USD Million)
Table 224 GCC Countries Neurostimulation Devices Market, by Type, 2022-2029 (USD Million)
Table 225 GCC Countries: Infusion Pumps Market, by Type, 2022-2029 (USD Million)
Table 226 GCC Countries: Ablation Devices Market, by Type, 2022-2029 (USD Million)
Table 227 GCC Countries: Pain Management Devices Market, by Application, 2022-2029 (USD Million)
Table 228 GCC Countries: Pain Management Devices Market, by Mode of Purchase, 2022-2029 (USD Million)
Table 229 GCC Countries: Pain Management Devices Market, by End-user, 2022-2029 (USD Million)
Table 230 Rest of Middle East & Africa: Pain Management Devices Market, by Type, 2022-2029 (USD Million)
Table 231 Rest of Middle East & Africa: Neurostimulation Devices Market, By Type, 2022-2029 (USD Million)
Table 232 Rest of Middle East & Africa: Infusion Pumps Market, by Type, 2022-2029 (USD Million)
Table 233 Rest of Middle East & Africa: Ablation Devices Market, by Type, 2022-2029 (USD Million)
Table 234 Rest of Middle East & Africa: Pain Management Devices Market, By Application, 2022-2029 (USD Million)
Table 235 Rest of Middle East & Africa: Pain Management Devices Market, By Mode of Purchase, 2022-2029 (USD Million)
Table 236 Rest of Middle East & Africa: Pain Management Devices Market, By End-user, 2022-2029 (USD Million)
Table 237 Pain Management Devices Market: Degree of Competition
Table 238 Type Footprint
Table 239 Region Footprint
Table 240 List of Start-Ups/SMEs
Table 241 Competitive Benchmarking of Start-Ups/SMEs
Table 242 Pain Management Devices Market: Product Approvals/Launches, January 2021-September 2024
Table 243 Pain Management Devices Market: Deals, January 2021-September 2024
Table 244 Pain Management Devices Market: Expansions, January 2021-September 2024
Table 245 Pain Management Devices Market: Others, January 2021-September 2024
Table 246 Medtronic: Company Overview
Table 247 Medtronic: Products Offered
Table 248 Medtronic: Product Approvals/Launches
Table 249 Boston Scientific Corporation: Company Overview
Table 250 Boston Scientific Corporation: Products Offered
Table 251 Boston Scientific Corporation: Deals
Table 252 Abbott Laboratories: Company Overview
Table 253 Abbott Laboratories: Products Offered
Table 254 Abbott Laboratories: Product Lunches/Approvals
Table 255 Nevro Corp.: Company Overview
Table 256 Nevro Corp: Products Offered
Table 257 Nevro Corp.: Product Approvals/Launches
Table 258 Nevro Corp.: Deals, January 2021- September 2024
Table 259 Becton, Dickinson and Company: Company Overview
Table 260 Becton, Dickinson and Company: Products Offered
Table 261 Becton, Dickinson and Company: Others
Table 262 Stryker: Company Overview
Table 263 Stryker: Products Offered
Table 264 Stryker: Expansions
Table 265 B. Braun SE: Company Overview
Table 266 B. Braun SE: Products Offered
Table 267 B. Braun SE: Deals
Table 268 B. Braun SE: Others
Table 269 Baxter: Company Overview
Table 270 Baxter: Products Offered
Table 271 Omron Corporation: Company Overview
Table 272 Omron Corporation: Products Offered
Table 273 Avanos Medical, Inc.: Company Overview
Table 274 Avanos Medical, Inc.: Products Offered
Table 275 Avanos Medical, Inc.: Deals
Table 276 Teleflex Incorporated: Company Overview
Table 277 Teleflex Incorporated: Products Offered
Table 278 Icu Medical, Inc.:Company Overview
Table 279 Icu Medical: Products Offered
Table 280 Icu Medical: Deals
Table 281 Nipro: Company Overview
Table 282 Nipro: Products Offered
Table 283 Nipro: Expansions
Table 284 Moog Inc.: Company Overview
Table 285 Moog Inc.: Products Offered
Table 286 Atricure, Inc.: Company Overview
Table 287 Atricure, Inc.: Products Offered
Table 288 Atricure, Inc.: Product Approvals/ Launches
Table 289 Micrel Medical Devices SA: Company Overview
Table 290 Micrel Medical Devices SA: Products Offered
Table 291 Zynex, Inc.: Company Overview
Table 292 Zynex, Inc.: Products Offered
Table 293 Enovis Corporation: Company Overview
Table 294 Enovis Corporation: Products Offered

Figure 1 Research Design
Figure 2 Supply-Side Market Size Estimation: Revenue Share Analysis
Figure 3 Revenue Share Analysis Illustration: Medtronic
Figure 4 CAGR Projections: Supply-Side Analysis
Figure 5 Top-Down Approach
Figure 6 Data Triangulation
Figure 7 Pain Management Devices Market, by Type, 2024 vs. 2029 (USD Million)
Figure 8 Neurostimulation Devices Market, by Type, 2024 vs. 2029 (USD Million)
Figure 9 Infusion Pumps Market, by Type, 2024 vs. 2029 (USD Million)
Figure 10 Ablation Devices Market, by Type, 2024 vs. 2029 (USD Million)
Figure 11 Pain Management Devices Market, by Application, 2024 vs. 2029 (USD Million)
Figure 12 Pain Management Devices Market, by Mode of Purchase, 2024 vs. 2029 (USD Million)
Figure 13 Pain Management Devices Market, by End-user, 2024 vs. 2029 (USD Million)
Figure 14 Pain Management Devices Market, by Region
Figure 15 Growing Demand for Long-Term Pain Management Among Geriatric Population to Drive Market
Figure 16 Neuropathic Pain and China to be Major Stakeholders in 2023
Figure 17 China to Fastest-Growing Market for Pain Management Devices During Forecast Period
Figure 18 Pain Management Devices Market Dynamics
Figure 19 Supply Chain Analysis
Figure 20 Porter's Five Forces Analysis
Figure 21 Pre-Market Notification: 510(K) Approvals for Medical Devices
Figure 22 Canada: Regulatory Approval Process for Medical Devices
Figure 23 Europe: Regulatory Approval Process for Medical Devices
Figure 24 Latin America: Regulatory Scenario
Figure 25 Brazil: Regulatory Approval Process for Medical Devices
Figure 26 Mexico: Regulatory Approval Process for Medical Devices
Figure 27 Patent Analysis, 2014-2024
Figure 28 Global Patent Applications, 2014-2024
Figure 29 Indicative Pricing of Pain Management Devices, by Type, 2023 (USD)
Figure 30 Influence of Stakeholders on Buying Process, by Type
Figure 31 Key Buying Criteria, by Type
Figure 32 Ecosystem Analysis
Figure 33 Value Chain Analysis
Figure 34 Trends and Disruptions Impacting Customers’ Businesses
Figure 35 Investment and Funding Scenario, 2019-2023
Figure 36 North America: Pain Management Devices Market Snapshot
Figure 37 Asia-Pacific: Pain Management Devices Market Snapshot
Figure 38 Key Player Strategies/Right to Win, 2021-2024
Figure 39 Revenue Analysis of Top Three Players, 2021-2023
Figure 40 Market Share Analysis of Key Players, 2023
Figure 41 Company Evaluation Matrix (Key Players), 2023
Figure 42 Company Footprint
Figure 43 Company Evaluation Matrix (Start-Ups/SMEs), 2023
Figure 44 Brand/Product Comparison
Figure 45 R&D Expenditure of Key Players, 2021-2023
Figure 46 EV/EBITDA of Key Vendors
Figure 47 Year-To-Date (YTD) Price Total Return and Five-Year Stock Beta of Key Vendors
Figure 48 Medtronic: Company Snapshot
Figure 49 Boston Scientific Corporation: Company Snapshot
Figure 50 Abbott Laboratories: Company Snapshot
Figure 51 Nevro Corp.: Company Snapshot
Figure 52 Becton, Dickinson and Company: Company Snapshot
Figure 53 Stryker: Company Snapshot
Figure 54 B. Braun SE: Company Snapshot
Figure 55 Baxter: Company Snapshot
Figure 56 Omron Corporation: Company Snapshot
Figure 57 Avanos Medical, Inc.: Company Snapshot
Figure 58 Teleflex Incorporated: Company Snapshot
Figure 59 Icu Medical: Company Snapshot
Figure 60 Nipro: Company Snapshot
Figure 61 Moog Inc.: Company Snapshot
Figure 62 Atricure, Inc.: Company Snapshot
Figure 63 Zynex, Inc.: Company Snapshot
Figure 64 Enovis Corporation: Company Snapshot